No abstract

The R-Fe-B (R, rare earth) sintered magnets prepared with different ratio of alloys of MM-Fe-B (MM, misch-metal) and Nd-Fe-B by dual alloy method were investigated. As expected, the high ratio of MM-Fe-B alloy degrades the hard magnetic properties heavily with intrinsic coercivity lower than 5 kOe. When the atomic ratio MM/R ≤ 21.5% the magnetic properties can reach a practical level of Br ≥ 12.1 kGs, Hcj ≥ 10.7 kOe, and (BH)max ≥ 34.0 MGOe. And the effect of Hcj enhancement by the grain boundary diffusion process is obvious when MM/R ≤ 21.5%. It is revealed that the decrement of intrinsic magnetic properties of R2Fe14B matrix phase is not the main reason of the degradation of the magnets with high MM ratio. The change of deteriorated microstructure together with phase component plays fundamental roles in low Hcj. In high MM ratio magnets, (a) after annealing, Ce atoms inside main phase are inclined to be segregated in the outer layer of the main phase grains; (b) there is no thin layer of Ce-rich phase as an analogue of Nd-rich phase to separate main phase grains; (c) excessive Ce tends to form CeFe2 grains.

No abstract

Lymphomatoid papulosis is part of a spectrum of CD30+ cutaneous lymphoproliferative disorders characterized by spontaneous tumor regression. The mechanism(s) of regression is unknown. In a recent study, a selective increase in CD30 ligand expression in regressing lesions of lymphomatoid papulosis and cutaneous CD30+ anaplastic large cell lymphoma was shown, suggesting that activation of the CD30 signaling pathway may be responsible for tumor regression, whereas no difference in Fas/Fas ligand expression was found between regressing and nonregressing lesions. Therefore we tested the effects of CD30 and Fas activation on three CD30+ cutaneous lymphoma cell lines (Mac-1, Mac-2 A, JK) derived from nonregressing tumors of two patients who had progressed from lymphomatoid papulosis to systemic anaplastic large cell lymphoma. To evaluate the effects of CD30 signaling, the cell lines were incubated with a CD30 agonistic antibody, HeFi-1. Proliferative responses, mitogen-activated protein kinase, and nuclear factor kappa B activities were determined with and without CD30 activation. Mac-1 and Mac-2 A showed increased proliferative responses to incubation with CD30 activating antibody, HeFi-1. Inhibition of the mitogen-activated protein kinase activity caused growth inhibition of the Mac-1, Mac-2 A, and JK cell lines. Activation of the Fas pathway induced apoptosis in all three cell lines. Taken together, these findings suggest that resistance to CD30-mediated growth inhibition provides a possible mechanism for escape of cutaneous anaplastic large cell lymphoma from tumor regression. Mitogen-activated protein kinase inhibitors are potential therapeutic agents for the treatment of advanced cutaneous anaplastic large cell lymphoma. J Invest Dermatol 115:1034-1040, 2000